Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes: A Randomized Controlled Trial
Eastern Virginia Medical School
110 participants
Feb 24, 2025
INTERVENTIONAL
Conditions
Summary
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Eligibility
Inclusion Criteria3
- Singleton gestation
- Known or new diagnosis of gestational diabetes without reason for medication
- Age >=18 to <=50
Exclusion Criteria6
- \- Non-English as primary language.
- Known or suspected fetal anomaly or aneuploidy.
- Known lower bowel disorder
- Known phenylketonuria
- Prisoners.
- Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Psyllium fiber supplement capsules, 2g soluble fiber per capsule. They will be instructed to take 4 capsules twice daily for a total of 16g supplemental soluble fiber per day. This will be continued throughout pregnancy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06867861